𝔖 Bobbio Scriptorium

✦ LIBER ✦

Verteporfin worth it for age-related macular degeneration in the UK?

Book ID: 121641689
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Weight: 137 KB
Volume: 370
Category: Article
ISSN: 1173-5503
DOI: 10.1007/BF03279283

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Verteporfin worth it for age-related mac

Verteporfin worth it for age-related macular degeneration in the UK?

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 140 KB

Photodynamic therapy with verteporfin fo

Photodynamic therapy with verteporfin for age-related macular degeneration

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Ranibizumab versus Verteporfin for Neova

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

✍ Brown, David M.; Kaiser, Peter K.; Michels, Mark; Soubrane, Gisele; Heier, Jeffr 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 324 KB

Verteporfin Therapy for Neovascular Age-

Verteporfin Therapy for Neovascular Age-Related Macular Degeneration in Indian Eyes

✍ Nazimul Hussain; Taraprasad Das; Rohit Khanna; Kallukuri Sumasri; Lakshmana Samu 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 144 KB

Verteporfin therapy of subfoveal choroid

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration

✍ Jost B. Jonas 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 42 KB

A Preliminary Benefit-Risk Assessment of

A Preliminary Benefit-Risk Assessment of Verteporfin in Age-Related Macular Degeneration

✍ Jason Wickens, Dr Kevin J. Blinder 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 115 KB